XSPA
XpresSpa Group, Inc. [XSPA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
XSPA Stock Summary
In the News
XSPA Financial details
Company Rating
Buy
Market Cap
54.52M
Income
-37.41M
Revenue
32.83M
Book val./share
0
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
363
Optionable
No
Shortable
Yes
Earnings
22 Nov 2022
P/E
-1.75
Forward P/E
-
PEG
0.01
P/S
1.4
P/B
1.78
P/C
65.5
P/FCF
-2.07
Quick Ratio
4.1
Current Ratio
4.41
Debt / Equity
0.59
LT Debt / Equity
0.33
-
-
EPS (TTM)
-0.3
EPS next Y
-
EPS next Q
-
EPS this Y
-1372.73%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-65.98%
Revenue last 5Y
2.23%
Revenue Q/Q
5.73%
EPS Q/Q
-96.37%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
9.36%
Inst Trans
0.96%
ROA
-57%
ROE
-89%
ROC
-0.66%
Gross Margin
9%
Oper. Margin
-90%
Profit Margin
-91%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.62-2.19
52W High
-
52W Low
-
RSI
33
Rel Volume
0.28
Avg Volume
597.29K
Volume
168.09K
Perf Week
45.52%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
2.14112
-
-
Volatility
0.09%, 0.08%
Prev Close
74.57%
Price
0.655
Change
81.44%
XSPA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 103.38 | 29.68 | 0.19 | 0.7 | 0.6 | |
| Net income per share | -76.78 | -12.98 | -2.03 | 0.03 | -0.35 | |
| Operating cash flow per share | -13.55 | -0.07 | -0.56 | 0.14 | -0.26 | |
| Free cash flow per share | -19.98 | -1.46 | -0.66 | 0.07 | -0.26 | |
| Cash per share | 7.02 | 1.34 | 2.01 | 1 | 0.45 | |
| Book value per share | 18.79 | -3.82 | 1.75 | 0.88 | 0.43 | |
| Tangible book value per share | 8.19 | -5.7 | 1.78 | 0.92 | 0.43 | |
| Share holders equity per share | 18.79 | -3.82 | 1.75 | 0.88 | 0.43 | |
| Interest debt per share | 21.28 | 7.54 | 0.23 | 0.13 | 0.15 | |
| Market cap | 75.59K | 1.1M | 53.04M | 212.26M | 61.34M | |
| Enterprise value | 5.16M | 8.35M | -28.32M | 120.57M | 56.41M | |
| P/E ratio | 0 | -0.05 | -0.59 | 73.37 | -1.88 | |
| Price to sales ratio | 0 | 0.02 | 6.33 | 2.88 | 1.1 | |
| POCF ratio | -0.01 | -9.76 | -2.12 | 14.58 | -2.54 | |
| PFCF ratio | -0.01 | -0.46 | -1.81 | 30.45 | -2.54 | |
| P/B Ratio | 0.01 | -0.18 | 0.68 | 2.29 | 1.54 | |
| PTB ratio | 0.01 | -0.18 | 0.68 | 2.29 | 1.54 | |
| EV to sales | 0.1 | 0.17 | -3.38 | 1.64 | 1.01 | |
| Enterprise value over EBITDA | -0.2 | -0.68 | 0.35 | 14.65 | -2.08 | |
| EV to operating cash flow | -0.79 | -73.89 | 1.13 | 8.28 | -2.33 | |
| EV to free cash flow | -0.53 | -3.5 | 0.96 | 17.3 | -2.33 | |
| Earnings yield | -492.2 | -19.24 | -1.71 | 0.01 | -0.53 | |
| Free cash flow yield | -128.09 | -2.16 | -0.55 | 0.03 | -0.39 | |
| Debt to equity | 0.93 | -1.51 | 0.11 | 0.15 | 0.35 | |
| Debt to assets | 0.28 | 0.33 | 0.08 | 0.11 | 0.2 | |
| Net debt to EBITDA | -0.19 | -0.59 | 1 | -11.14 | 0.18 | |
| Current ratio | 0.35 | 0.24 | 6.81 | 5.5 | 4.32 | |
| Interest coverage | -19.01 | -5.47 | -21.89 | -34.47 | 0 | |
| Income quality | 0.18 | 0.01 | 0.28 | 4.35 | 0.74 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.32 | 0.3 | 1.9 | 0.33 | 0.56 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.3 | 0.24 | 0.01 | 0.03 | 0.11 | |
| Capex to operating cash flow | 0.47 | 20.13 | 0.17 | -0.52 | 0 | |
| Capex to revenue | -0.06 | -0.05 | -0.52 | -0.1 | 0 | |
| Capex to depreciation | -0.33 | -0.37 | -0.6 | -1.54 | 0 | |
| Stock based compensation to revenue | 0.02 | 0.01 | 0.16 | 0.04 | 0.07 | |
| Graham number | 180.19 | 33.4 | 8.93 | 0.74 | 1.83 | |
| ROIC | -1.96 | -1.24 | -0.42 | 0.03 | -0.48 | |
| Return on tangible assets | -1.74 | -0.97 | -0.88 | 0.02 | -0.52 | |
| Graham Net | -28.18 | -17.59 | 1.51 | 0.76 | 0.24 | |
| Working capital | -10.9M | -12.29M | 78.3M | 89.15M | 36.38M | |
| Tangible asset value | 3.97M | -9.32M | 79.5M | 96.2M | 39.92M | |
| Net current asset value | -11.69M | -27.33M | 69.02M | 81.65M | 24.86M | |
| Invested capital | 0.93 | -1.51 | 0.11 | 0.15 | 0.35 | |
| Average receivables | 400K | 0 | 0 | 307.5K | 1.74M | |
| Average payables | 3.59M | 5.45M | 4.75M | 4.2M | 4.14M | |
| Average inventory | 970.5K | 714.5K | 652K | 1.21M | 1.46M | |
| Days sales outstanding | 0 | 0 | 0 | 3.04 | 18.65 | |
| Days payables outstanding | 35.39 | 68.16 | 74.32 | 52.62 | 19.23 | |
| Days of inventory on hand | 7.24 | 6.24 | 20.01 | 15.55 | 9.65 | |
| Receivables turnover | 0 | 0 | 0 | 119.88 | 19.57 | |
| Payables turnover | 10.31 | 5.35 | 4.91 | 6.94 | 18.98 | |
| Inventory turnover | 50.45 | 58.51 | 18.24 | 23.47 | 37.8 | |
| ROE | -4.09 | 3.4 | -1.16 | 0.03 | -0.82 | |
| Capex per share | -6.43 | -1.39 | -0.1 | -0.07 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.14 | 0.11 | 0.08 | 0.08 | 0 | |
| Net income per share | -0.08 | -0.08 | -0.15 | -0.07 | 0 | |
| Operating cash flow per share | -0.07 | -0.09 | -0.07 | -0.07 | 0 | |
| Free cash flow per share | -0.05 | -0.11 | -0.06 | -0.07 | 0 | |
| Cash per share | 0.75 | 0.52 | 0 | 0.42 | 0.01 | |
| Book value per share | 0.75 | 0.56 | 0 | 0.42 | 0 | |
| Tangible book value per share | 0.74 | 0.56 | 0 | 0.42 | 0.01 | |
| Share holders equity per share | 0.75 | 0.56 | 0 | 0.42 | 0 | |
| Interest debt per share | 0.12 | 0.16 | 0 | 0.16 | 0 | |
| Market cap | 65.84M | 72.39M | 61.34M | 54.59M | 2.73B | |
| Enterprise value | 6.62M | 38.17M | 61.34M | 58.05M | 2.74B | |
| P/E ratio | -2.08 | -2.36 | -1.07 | -2.48 | -68.91 | |
| Price to sales ratio | 4.84 | 6.74 | 8.12 | 7.73 | 366.08 | |
| POCF ratio | -9.62 | -8.23 | -9.05 | -9.31 | 0 | |
| PFCF ratio | -14.06 | -6.88 | -11.61 | -9.31 | 0 | |
| P/B Ratio | 0.92 | 1.37 | 0 | 1.57 | 140.92 | |
| PTB ratio | 0.92 | 1.37 | 0 | 1.57 | 140.92 | |
| EV to sales | 0.49 | 3.56 | 8.12 | 8.22 | 366.98 | |
| Enterprise value over EBITDA | -1.11 | -7.62 | -4.23 | -11.07 | -291.92 | |
| EV to operating cash flow | -0.97 | -4.34 | -9.05 | -9.9 | 0 | |
| EV to free cash flow | -1.41 | -3.63 | -11.61 | -9.9 | 0 | |
| Earnings yield | -0.12 | -0.11 | -0.23 | -0.1 | 0 | |
| Free cash flow yield | -0.07 | -0.15 | -0.09 | -0.11 | 0 | |
| Debt to equity | 0.17 | 0.29 | 0 | 0.38 | 0.59 | |
| Debt to assets | 0.12 | 0.18 | 0 | 0.21 | 0.26 | |
| Net debt to EBITDA | 9.89 | 6.83 | 0 | -0.66 | -0.71 | |
| Current ratio | 5.93 | 5.02 | 0 | 4.41 | 3.67 | |
| Interest coverage | -879.56 | -93.42 | 374.97 | 0 | 0 | |
| Income quality | 1.07 | 1.14 | 0.48 | 1.01 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.56 | 0.6 | 0.92 | 0.86 | 0.48 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.09 | 0.1 | 0 | 0.12 | 0.05 | |
| Capex to operating cash flow | -0.32 | 0.2 | -0.22 | 0 | 0 | |
| Capex to revenue | 0.16 | -0.16 | 0.2 | 0 | 0 | |
| Capex to depreciation | 1.12 | -0.83 | -5.84 | 0 | 0 | |
| Stock based compensation to revenue | -0.11 | 0.04 | 0.43 | 0.09 | 0 | |
| Graham number | 1.18 | 1.01 | 0 | 0.79 | 0.02 | |
| ROIC | -0.08 | -0.09 | 0 | -0.09 | -0.1 | |
| Return on tangible assets | -0.09 | -0.1 | 0 | -0.1 | -0.23 | |
| Graham Net | 0.53 | 0.3 | 0 | 0.21 | 0 | |
| Working capital | 61.83M | 44.2M | 0 | 30.84M | 21.81M | |
| Tangible asset value | 70.93M | 53.09M | 0 | 34.94M | 25.1M | |
| Net current asset value | 52.94M | 31.73M | 0 | 19.89M | 12.68M | |
| Invested capital | 0.17 | 0.29 | 0 | 0.38 | 0.59 | |
| Average receivables | 1.38M | 1.77M | 1.35M | 1.01M | 0 | |
| Average payables | 4.64M | 6.47M | 1.82M | 1.16M | 0 | |
| Average inventory | 1.79M | 1M | 470K | 497.5K | 0 | |
| Days sales outstanding | 5.51 | 22.69 | 0 | 25.68 | 14.38 | |
| Days payables outstanding | 124.06 | 35.1 | 0 | 31.89 | 21.33 | |
| Days of inventory on hand | 14.22 | 9.06 | 0 | 13.69 | 13.66 | |
| Receivables turnover | 16.34 | 3.97 | 0 | 3.51 | 6.26 | |
| Payables turnover | 0.73 | 2.56 | 0 | 2.82 | 4.22 | |
| Inventory turnover | 6.33 | 9.94 | 0 | 6.57 | 6.59 | |
| ROE | -0.11 | -0.15 | 0 | -0.16 | -0.51 | |
| Capex per share | 0.02 | -0.02 | 0.02 | 0 | 0 |
XSPA Frequently Asked Questions
What is XpresSpa Group, Inc. stock symbol ?
XpresSpa Group, Inc. is a US stock , located in New york city of New york and trading under the symbol XSPA
What is XpresSpa Group, Inc. stock quote today ?
XpresSpa Group, Inc. stock price is $0.655 today.
Is XpresSpa Group, Inc. stock public?
Yes, XpresSpa Group, Inc. is a publicly traded company.
Company Profile
- Volume Average 597.29K
- Market Capitalization 54.52M
- Employee 363
- CEO Mr. Douglas Satzman
- Headquarters New York City,NEW YORK,US
- IPO Date 2010-06-18
-
Website
https://www.xpresspagroup.com 
XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
